Gene therapy injection aims to lower eye pressure in glaucoma patients
Disease control
Recruiting now
This early-stage trial tests a gene therapy called GVB-2001 for people with primary open-angle glaucoma, a common eye disease that damages the optic nerve due to high pressure inside the eye. The treatment is given as a single injection into the eye. The study will enroll 6 adult…
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC